Sjm™ 3701

• FDA PMA P010032 decided 21 Nov 2001 Active
• FDA GUDID UDI-DI 05414734402477 listed 13 Nov 2014 Listed

• • Ongoing Z-0458-2026 FDA Class II ·initiated 6 Oct 2025

  There is a potential issue affecting Eterna Spinal Cord Stimulation (SCS) Implantable Pulse Generators (IPGs), Model 32400 and Liberta RC Deep Brain Stimulation (DBS) Implantable Pulse Generators (IPGs), Model 62400 . These devicess may experience a loss of communication with the Clinician Programmer (CP) and/or the Patient Controller (PC).

• 7 recalls, same reason

  • Ongoing Z-2508-2023 FDA Class I ·initiated 18 Jul 2023
  • Ongoing Z-2511-2023 FDA Class I ·initiated 18 Jul 2023
  • Ongoing Z-2509-2023 FDA Class I ·initiated 18 Jul 2023
  • Ongoing Z-2510-2023 FDA Class I ·initiated 18 Jul 2023
  • Ongoing Z-2507-2023 FDA Class I ·initiated 18 Jul 2023
  • Ongoing Z-2505-2023 FDA Class I ·initiated 18 Jul 2023
  • Ongoing Z-2506-2023 FDA Class I ·initiated 18 Jul 2023

  Firm has received complaints from patients who are unable to exit MRI (Magnetic Resonance Imaging) mode on their IPGs (Implantable Pulse Generators).

• 2 recalls, same reason

  • Terminated Z-2692-2017 FDA Class II ·initiated 2 Jun 2017
  • Terminated Z-2691-2017 FDA Class II ·initiated 2 Jun 2017

  The firm discovered a risk of loss of Neuromodulation therapy due to exposure of the IPG to monopolar electrosurgical devices (ESU) during medical procedures.

• • Terminated Z-1785-2013 FDA Class II ·initiated 30 Nov 2012

  There is issues of warmth or heating at the implant site during charging for the Eon Mini implantable pulse generators (IPGs). In the July 2012 letter St. Jude Medical informed customers that they would be implementing design improvements to the charger to address possible increased energy dissipation when the charger is misaligned with the IPG or the IPG is implanted too near the surface of the

• • Terminated Z-0025-2013 FDA Class II ·initiated 4 Sep 2012

  Eon Mini IPGs manufactured in April 2012 could potentially exhibit a sudden, brief surge in stimulation that would be felt by the patient as uncomfortable or painful. SJMs routine testing, monitoring, and analysis of manufacturing processes identified three lots of Eon Mini IPGs that the internal battery has the potential to come into contact with the internal microcontroller board.

• • Terminated Z-1738-2013 FDA Class II ·initiated 26 Jul 2012

  St. Jude Medical has informed your doctor that a number of cases have been reported in which discomfort associated with heating occurred at the device site while patients were using the Charging System to charge their spinal cord stimulator. In three cases, patients received a burn to the skin (one second-degree and two first-degree burns) at the implant site. As of June 30, 2012, St. Jude Medica

• • Terminated Z-3091-2011 FDA Unclassified (pre-2012) ·initiated 2 Jun 2009

  Product programmed with unapproved software was distributed.

1. 2 Jun 2017 Recall initiated FDA recalls Z-2692-2017
2. 2 Jun 2017 Recall initiated FDA recalls Z-2691-2017
3. 18 Jul 2023 Recall initiated FDA recalls Z-2508-2023
4. 18 Jul 2023 Recall initiated FDA recalls Z-2511-2023
5. 18 Jul 2023 Recall initiated FDA recalls Z-2509-2023
6. 18 Jul 2023 Recall initiated FDA recalls Z-2510-2023
7. 18 Jul 2023 Recall initiated FDA recalls Z-2507-2023
8. 18 Jul 2023 Recall initiated FDA recalls Z-2505-2023
9. 18 Jul 2023 Recall initiated FDA recalls Z-2506-2023
10. 6 Oct 2025 Recall initiated FDA recalls Z-0458-2026

6 earlier events are in the sections above.

Trade name

Sjm™

Generic name

Noninvasive device battery charger

Model / Ref / Catalog

3701

Primary DI / UDI-DI

05414734402477

PMA number

P010032 ↗

FDA product code

LGW

GMDN term

Noninvasive device battery charger

Device class

Class III

GUDID distribution status

In Commercial Distribution

Category: Noninvasive device battery charger

Other devices filed under Noninvasive device battery charger.

• Cochlear™ Y Battery Charger P1842636 by Cochlear
• Cochlear™ USB Battery Charger Z544581 by Cochlear
• Sonicision CBCA by Covidien LP
• INVOS PMAC71DOC by Covidien LP

• MN13650

  Class III

  FDA PMA P150004 Active Approved 11 Feb 2016 GUDID on market

• 1210 Open recall

  Class III

  FDA PMA ×3 Active Approved 21 Nov 2001 GUDID on market

• Infinity™ 6884 Open recall

  Class III

  FDA PMA P140009 Active Approved 12 Jun 2015 GUDID on market

• Proclaim™ 3884 Open recall

  Class III

  FDA PMA P010032 Active Approved 21 Nov 2001 GUDID on market

See all devices from Advanced Neuromodulation Systems →